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Abstract  
DISC1 is a multifunctional, intracellular scaffold protein. At the cellular level, DISC1 plays a pivotal 
role in neural progenitor proliferation, migration, and synaptic maturation. Perturbation of the biological 
pathways involving DISC1 is known to lead to behavioral changes in rodents, which supports a clinical 
report of a Scottish pedigree in which the majority of family members with disruption of the DISC1 
gene manifest depression, schizophrenia, and related mental conditions. The discrepancy of modest 
evidence in genetics but strong biological support for the role of DISC1 in mental conditions suggests a 
working hypothesis that regulation of DISC1 at the protein level, such as posttranslational modification, 
may play a role in the pathology of mental conditions. In this study, we report the SUMOylation of 
DISC1. This posttranslational modification occurs on lysine residues where small ubiquitin-related 
modifier (SUMO) and its homologs are conjugated to a large number of cellular proteins, which in turn 
regulates their subcellular distribution and protein stability. By using in silico, biochemical, and cell 
biological approaches, we now demonstrate that human DISC1 is SUMOylated at one specific lysine 
643 (K643). We also show that this residue is crucial for proper neural progenitor proliferation in the 
developing cortex. 
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Introduction 
Over the past several decades, we have used genetic and neuropathological approaches to explore 
compelling molecular leads to address the mechanisms of neurological and neuropsychiatric disorders 
[1-3].  For example, tau and α-synuclein proteins have been underscored as major components of 
inclusion bodies that occur in the brains of patients with Alzheimer’s disease and Parkinson’s disease, 
respectively [4, 5]. The tau and α-synuclein proteins are pathologically phosphorylated [6, 7], and the 
pathological roles of these posttranslational modifications have been elucidated [8]. Likewise, 
pathological implications of other posttranslational modifications have also been reported [9].   
 The DISC1 locus has received broad attention in the context of psychiatric illness, since a 
balanced translocation that segregated in a Scottish pedigree with schizophrenia and depression was 
reported [10]. Since the discovery of the gene, many neurobiologists have studied the biological function 
of DISC1. At the cellular level, DISC1 plays a pivotal role in neural progenitor proliferation, migration, 
and synaptic maturation. Perturbation of the biological pathways involving DISC1 is known to lead to 
behavioral changes in rodents. In contrast to biological results that support the role for DISC1 in mental 
conditions, genetic evidence to support the contribution of the DISC1 gene in sporadic schizophrenia has 
been modest. The discrepancy of modest evidence in genetics but strong biological support for the role 
of DISC1 in mental conditions led us to propose a working hypothesis that regulation of DISC1 at the 
protein level, such as posttranslational modification, may play a role in its function in pathology.  
 DISC1 is located in multiple subcellular domains, including the centrosome, postsynaptic 
density, and the nucleus [11-13]. Like tau and α-synuclein, specific phosphorylation on DISC1 affects 
its localization to the centrosome and plays a crucial role in neurodevelopment [14]. Protein targeting to 
the nucleus is also influenced by posttranslational modifications, such as SUMOylation [15]. 
SUMOylation occurs on lysine residues whereby small ubiquitin-related modifiers (SUMO) and 
homologs are conjugated to proteins [16]. SUMOylation has emerged as a major regulator of nuclear 
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function, including DNA replication, DNA damage response, and transcription [17-19]. Furthermore, an 
important role for SUMOylation in protein trafficking to the nucleus has also been reported [20].  
 In the present study, we show that human DISC1 is SUMOylated at lysine 643 (K643) with in 
silico, biochemical, and cell biological approaches. This specific SUMOylation site of DISC1 regulates 
neural progenitor proliferation in the developing cortex. 
 
Methods 
Animals 
Pregnant C57BL/6 mice were purchased from Charles River. All animal care and use was in accordance 
with guidelines for the care and use of laboratory animals issued by the National Institutes of Health and 
Johns Hopkins University. 
 
Constructs and antibodies 
A K643A variant of human DISC1 or a K640A variant of mouse DISC1 (mDISC1) was introduced by 
PCR-based mutagenesis as mentioned previously [14]. All constructs in the present study were created 
as described previously [12, 21]. We used short hairpin RNA (shRNA) construct of DISC1 that have 
been published previously [12]. GFP-tagged SUMO1, FLAG-tagged SUMO1, and Myc-tagged Ubc9 
constructs were generous gifts from Dr. Pandolfi (Beth Israel Deaconess Cancer Center, USA), Dr. 
Hayward (Johns Hopkins University, USA), and Dr. Matunis (Johns Hopkins School of Public Health, 
USA), respectively. The following antibodies were used: mouse monoclonal anti-HA antibody 
(Covance); rabbit polyclonal anti-FLAG antibody (Sigma); rabbit polyclonal anti-SUMO1 antibody 
(Zymed); mouse monoclonal anti-BrdU antibody (BD Biosciences); and a rabbit polyclonal anti-human 
DISC1 antibody (kindly provided by Dr. Akiyama, University of Tokyo, Japan) [22]. 
 
In silico prediction of SUMOylation site(s) in DISC1 
 5 
Prediction of DISC1 SUMOylation sites was determined by using the SUMOplot
TM
 Analysis Program 
from ABGENT available at http://www.abgent.com/sumoplot. The score indicates the probability that 
the targeted lysine is SUMOylated. 
 
Recombinant proteins 
To obtain C-terminal DISC1 fragmented glutathione S-transferase (GST) fusion proteins, the C-terminal 
of DISC1 (amino acids 598-854) was inserted into pGEX vector. The expression plasmids were 
introduced into BL21 competent E. coli with 0.1 mM IPTG. Recombinant proteins were purified from 
E. coli with glutathione sepharose or amylase beads. 
 
In vitro SUMOylation assay 
In vitro SUMOylation was assayed by use of the SUMOylation assay kit (Boston Biochem). Briefly, 
reactions contained 10 µg of GST-DISC1-C, 50 µM SUMO proteins, 100 nM SUMO activating 
enzyme, E1, 5 µM UbcH9, and 1mM Mg-ATP in buffer (50 mM HEPES, pH 8.0, 100 mM NaCl, 1 mM 
DTT), and were incubated at 37˚C for 2 h. The reactions were also run in the absence of ATP as a 
negative control. Proteins were run on NuPAGE 4-12% Bis-Tris gel (Invitrogen) and visualized with 
SimplyBlue SafeStain (Invitrogen). 
 
Ubc9 fusion-directed SUMOylatin (UFDS) assay 
UFDS assay was performed as previously described [21] with minor modifications. Briefly, HEK293 
cells were transfected with the construct of DISC1-Ubc9 or DISC1-Ubc9(C93S) together with the 
SUMO1-GFP construct, and lysed 48 h after transfection. Immunoblots were conducted with the anti-
DISC1 antibody described above [22]. 
 
Cell culture 
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COS7 cells were used to assay SUMOylation on DISC1. Cells were grown in Dulbecco’s modified 
Eagle's medium (DMEM) with 10% FBS. The expression constructs were transfected into cells by using 
FuGENE
®
6 (Roche Applied Sciences). 
 
Immunoprecipitation 
Cells were lysed in a RIPA buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 5 mM DTT, 1 
mM PMSF, 1 mM EDTA, 1% Triton X-100) containing protease inhibitor mixture (Roche Applied 
Sciences). Supernatant fractions were obtained from lysates after centrifugation at 13 000 rpm for 15 
min. Soluble fractions were used for immunoprecipitation as described previously [14]. 
 
In utero electroporation 
Pregnant C57BL/6 mice at embryonic (E) day 13 were deeply anesthetized by intraperitoneal 
administration of 2,2,2-tribromoethanol in tert-amyl alcohol (0.4 mg/g), and intrauterine embryos were 
surgically manipulated as described previously [12, 23]. Plasmid solutions in volumes of 1-2 µl 
containing RNAi plasmids (2 µg/µl) together with CAG-driven GFP expression vector (1 µg/µl) were 
injected into the lateral ventricles, and electronic pulses (35 V, 50 ms, 4 times) were applied using an 
electroporator (CUY21E, Tokiwa Science) with forceps-type electrode (CUY650-5, Tokiwa Science). 
 
BrdU incorporation assay and brain slice preparation 
Incorporation of BrdU was assayed was performed as previously described [14] with minor 
modifications. 50 mg/kg BrdU (Sigma) was injected intraperitoneally into E13 pregnant mice 48 h after 
electroporation. Then 2 h after BrdU injection, brains were fixed with 4% paraformaldehyde, and 20 µm 
coronal sections were obtained with a cryostat (CM 1850, Leica). For BrdU immunostaining, brain 
slices were incubated in 2 N HCl at 37˚C for 30 min before incubation with mouse anti-BrdU antibody. 
Images of the slices were acquired with a confocal microscope (Zeiss LSM510 and Olympus FV300). 
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Statistical analysis 
To compare four groups, one-way ANOVA followed by Bonferroni post hoc for multiple comparisons 
test was used. p < 0.05 were considered to be statistically significant (*p < 0.05). 
 
Results 
SUMOylation of C-terminal DISC1 at lysine residue 643 (K643) in vitro 
DISC1 is found at multiple subcellular domains, and its nuclear localization and biological roles have 
been demonstrated [24]. This subcellular targeting may be determined in part by posttranslational 
modifications [14]. As a role of SUMOylation for targeting proteins to the nucleus is known [15], we 
hypothesized that a pool of DISC1 may be SUMOylated. We thus first predicted the SUMOylation 
site(s) in DISC1 by using a bioinformatics approach with the ABGENT SUMOplot 
(http://www.abgent.com/sumoplot). By this method, DISC1 at lysine residue 643 (K643) was identified 
as a strong candidate SUMOylation site (Fig. 1a). Since K643 is in the C-terminus of DISC1, we 
assayed in vitro SUMOylation with GST-tagged C-terminal DISC1 protein spanning amino acid 
residues 598-854 (DISC1-C). In the presence of ATP, which is crucial for SUMO-protein conjugation, 
DISC1-C was SUMOylated by SUMO1, SUMO2, or SUMO3 (Fig. 1b). Next, to confirm whether K643 
is essential for SUMOylation in DISC1-C, we performed in vitro SUMOylation assays using mutant 
DISC1-C where lysine residue 643 was substituted into alanine (DISC1-C-K643A). Even in the 
presence of ATP, DISC1-C-K643A was not SUMOylated by SUMO1 (Fig 1c). Thus, these results 
indicate that C-terminal DISC1 protein is SUMOylated at lysine residue 643 in vitro. 
 
SUMOylation of DISC1 at K643 in cells 
Next, to test whether the SUMOylation of DISC1 occurs in cells, we exogenously expressed DISC1-C 
together with SUMO1 in cells and examined whether DISC1-C is conjugated to SUMO. DISC1-C and 
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SUMO1 were indeed co-immunoprecipitated, and a signal for the immunoprecipitated protein complex 
was observed at an expected size of SUMOylated DISC1-C, 70 kDa (red arrowhead in IP panel in Fig. 
2a). Of note, a signal for SUMOylation of DISC1-C was also observed in the lysates (red arrowhead in 
Input panel in Fig. 2a). Then, to determine whether K643 is the SUMOylation site in DISC1-C in cells, 
we examined whether the mutation in which lysine residue 643 was replaces with alanine (K643A) in C-
terminal of DISC1 interfered with the SUMOylation. Immunoblotting with cells transfected with 
DISC1-C showed a strong signal at 70 kDa that represents SUMOylated DISC1-C, whereas such a 
signal was abolished in cells expressed with DISC1-C-K643A (Fig. 2b). These results suggest that the 
SUMOylation of DISC1-C occurs at lysine residue 643 in cells.  
 We next assessed whether the full-length DISC1 could also be SUMOylated in cells. Strong 
signal that represents SUMOylated DISC1 was detected when DISC1-Ubc9, which enhances the 
SUMOylation, was exogenously expressed together with SUMO1 in cells (red arrowhead). This 
SUMOylation on DISC1 was abolished by co-expression of SUMO1 with DISC1-Ubc9(C93S), a 
dominant negative form of Ubc9 (Fig. 2c).  
To address the question whether K643 is the main SUMOylation site on full-length DISC1, we 
compared potential SUMOylation between wild-type full-length DISC1 (DISC1) and full-length DISC1-
K643A (DISC1-K643A). Cells were co-expressed with DISC1 or DISC1-K643A together with SUMO1 
and Ubc9. DISC1 and SUMO1 were co-immunoprecipitated, and a signal for the immunoprecipitated 
protein complex was observed at an expected size of SUMOylated DISC1, 125 kDa (red arrowhead in 
IP panel in Fig. 2d), whereas such a signal was abolished in cells expressed with DISC1-K643A. Of 
note, a signal for SUMOylation of DISC1 was also observed in the lysates (red arrowhead in Input panel 
in Fig. 2d). On the basis of these results, K643 is considered the main SUMOylation site on full-length 
DISC1. 
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K640 SUMOylation site in mouse DISC1 (mDISC1) (corresponding to K643 in human DISC1) is crucial 
for proper proliferation of neural progenitor cells (NPCs) in the developing cortex 
Previous studies have shown that DISC1 modulates NPCs proliferation in vivo [14, 25]. Thus, we tested 
how the K640 SUMOylation site in mDISC1 affected the proliferation of NPCs by in utero gene transfer 
combined with BrdU pulse-labeling. Consistent with our previous study [14], the proportion of cells 
incorporating BrdU was significantly decreased in brains with mDISC1 knockdown (mDISC1 RNAi) 
compared to control, indicating that NPC proliferation was impaired. These knockdown effects were 
ameliorated by co-expression with wild type mDISC1, but not by mDISC1-K643A (Fig. 3), suggesting 
that the K640 SUMOylation site in mDISC1 is crucial for proper proliferation of NPCs in the 
developing cortex.  
 
Discussion 
Here we report that DISC1 protein is SUMOylated. By combinig in silico, biochemical, and cell 
biological approaches, we have determined that lysine 643 in human DISC1 (which corresponds to 
lysine 640 in mouse DISC1) is a major SUMOylation site. We show that mutation in this residue leads 
to improper neural progenitor proliferation in the developing cortex.  
 Thus far, several papers have indicated a role for nuclear DISC1 [14, 25]. By examining 
autopsied brains from patients with neuropsychiatric conditions, Sawamura et al. [26] suggested that 
nuclear DISC1 in the orbitofrontal cortex may be involved in substance abuse. The Furukubo-Tokunaga 
lab [27] reported that DISC1 is involved in the regulation of sleep homeostasis, in particular in 
association with nuclear DISC1. More recently, the Tsai lab [28] has demonstrated that nuclear DISC1 
is crucial for the regulation of phosphodiesterase-cyclic AMP signaling that underlies multiple 
psychiatric conditions. Taken together, although each study is still independent without a cohesive or 
integrative story of nuclear DISC1 function yet, studying nuclear DISC1 will be important in studying 
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the pathological mechanisms for mental illnesses. We hope that SUMOylation at K643 in human DISC1 
may be a solid molecular probe to lead such mechanistic studies.  
 Here we observed that the replacement of lysine with alanine at a critical SUMOylation site 
(mouse K640 that corresponds to human K643) disturbed neural progenitor proliferation in the 
developing cortex. Although this is not a direct demonstration that SUMOylation of DISC1 is crucial for 
the neurodevelopmental process, we believe this is very suggestive evidence. To address this question in 
a more direct manner, although it is beyond the scope of the present study, we may need to develop anti-
SUMOylation specific DISC1 antibodies. Equivalent antibodies have been frequently used as tools to 
study protein phosphorylation [29], and indeed applied to a study in DISC1 in the past [14]. There is 
thus a successful precedence for using anti-SUMOylation specific antibodies in biomedical studies [7, 
30]. Such posttranslational modification-specific antibodies may become useful probes to study the 
pathology of mental illness.  
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Figure legends 
Figure 1. SUMOylation of C-terminal DISC1 at lysine residue 643 (K643) in vitro 
a, DISC1 SUMOylation sites predicted by use of the ABGENT SUMOplot
TM
.  
b, In vitro SUMOylation assay with GST-tagged C-terminal DISC1 (DISC1-C). Coomassie blue-
staining showed that DISC1-C was covalently conjugated to SUMO1, SUMO2, and SUMO3. Red 
arrowheads indicate SUMOylated forms of DISC1-C.  
c, In vitro SUMOylation assay with GST-tagged C-terminal DISC1 (DISC1-C) or mutant C terminal 
DISC1 where K643 was substituted by alanine (DISC1-C-K643A). Immunoblotting showed that 
DISC1-C but not DISC1-C-K643A was SUMOylated. Red arrowheads indicate SUMOylated forms of 
DISC1-C. 
 
Figure 2. SUMOylation of DISC1 at lysine residue 643 (K643) in cells 
a, Conjugation of HA-DISC1-C with FLAG-SUMO1 (SUMOylation of DISC1) was shown in COS7 
cells. COS7 cells were transfected with HA-DISC1-C and/or FLAG-SUMO1. Cell lysates were 
immunoprecipitated with anti-FLAG antibody and the immunoprecipitates were blotted with anti-HA 
antibody. Red arrowheads indicate SUMOylated forms of DISC1-C at 70 kDa.  
b, COS7 cells were transfected with HA-DISC1-C or HA-DISC1-C-K643A. Cells with HA-DISC1-C 
showed a strong signal at 70 kDa, which represents a SUMOylated form of DISC1-C, suggesting 
SUMOylation of DISC1 with endogenous SUMO protein. This signal was significantly abolished in 
cells transfected with HA-DISC1-C-K643A. Red arrowhead indicates SUMOylated forms of DISC1-C 
at 70-kDa.  
c, SUMOylation of full-length DISC1 was shown in HEK293 cells by Ubc9 fusion-directed 
SUMOylation (UFDS) assay. SUMO1-GFP fusion was co-transfected with DISC1-Ubc9, an E2 SUMO 
conjugating enzyme fusion, or DISC1-Ubc9(C93S), a dominant negative form of Ubc9 fusion, in 
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HEK293 cells. Cell lysates were immunoblotted with anti-DISC1 antibody. Red arrowhead indicates 
SUMOylated forms of DISC1.  
d, COS7 cells were co-transfected with HA-DISC1 or HA-DISC1-K643A together with FLAG-SUMO1 
and myc-Ubc9. Cell lysates were immunoprecipitated with anti-HA antibody and the 
immunoprecipitates were blotted with anti-FLAG antibody. Signals for SUMOylated full-length DISC1 
were observed at 125 kDa in cells transfected with HA-DISC1 (red arrowheads), whereas almost no 
signals were found at 125-kDa in cells transfected with HA-DISC1-K643A.  
 
Figure 3. K640 SUMOylation site in mouse DISC1 (mDISC1), corresponding to K643 in human 
DISC1, is crucial for proper proliferation of neural progenitor cells (NPCs) in vivo 
Images show E15 brains that were electroporated with GFP together with control shRNA, mDISC1 
shRNA, mDISC1 shRNA + wild-type (wt) mDISC1, or mDISC1 shRNA + mDISC1-K640A at E13. 
BrdU was injected 2 h before brain extraction. The proportion of BrdU incorporating cells in the 
ventricular and subventricular zone (VZ/SVZ) in brains with mDISC1 shRNA, was significantly lower 
than that in brains with control shRNA. This phenotype was rescued by wt mDISC1 but not by 
mDISC1-K640A. Graph shows the proportion of GFP/BrdU double-positive cells over total GFP 
positive cells in the VZ/SVZ. Scale bar, 20µm. Error bars indicate s.e.m. *P<0.05. 
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